atp synthase (complex v) Search Results


antibodies against different subunits respiratory complex atp synthase (complex v  (MitoSciences)
90
MitoSciences antibodies against different subunits respiratory complex atp synthase (complex v
Antibodies Against Different Subunits Respiratory Complex Atp Synthase (Complex V, supplied by MitoSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/antibodies+against+different+subunits+respiratory+complex+atp+synthase++complex+v/10__1016_slash_j__bmhime__2017__11__025-50-14-18
Average 90 stars, based on 1 article reviews
antibodies against different subunits respiratory complex atp synthase (complex v - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
f1α atp synthase (complex v) antibody  (MitoSciences)
90
MitoSciences f1α atp synthase (complex v) antibody
F1α Atp Synthase (Complex V) Antibody, supplied by MitoSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/f1%CE%B1+atp+synthase++complex+v++antibody/pm17582388-83-56-34
Average 90 stars, based on 1 article reviews
f1α atp synthase (complex v) antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
atp synthase / complex v inhibitor #495455  (Merck KGaA)
90
Merck KGaA atp synthase / complex v inhibitor #495455
Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of <t>oligomycin,</t> CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).
Atp Synthase / Complex V Inhibitor #495455, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/atp+synthase+++complex+v+inhibitor++495455/pmc11103502-95-17-24
Average 90 stars, based on 1 article reviews
atp synthase / complex v inhibitor #495455 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
atp synthase (complex v)  (MitoQ Ltd)
90
MitoQ Ltd atp synthase (complex v)
Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of <t>oligomycin,</t> CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).
Atp Synthase (Complex V), supplied by MitoQ Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/atp+synthase++complex+v+/10__1113_slash_jp284786-170-12-27
Average 90 stars, based on 1 article reviews
atp synthase (complex v) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
atp synthase complex v  (MitoSciences)
90
MitoSciences atp synthase complex v
Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of <t>oligomycin,</t> CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).
Atp Synthase Complex V, supplied by MitoSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/atp+synthase+complex+v/pm35679966-149-40-57
Average 90 stars, based on 1 article reviews
atp synthase complex v - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
monoclonal antibody raised against the complete mitochondrial atp synthase (complex v)  (MitoSciences)
90
MitoSciences monoclonal antibody raised against the complete mitochondrial atp synthase (complex v)
Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of <t>oligomycin,</t> CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).
Monoclonal Antibody Raised Against The Complete Mitochondrial Atp Synthase (Complex V), supplied by MitoSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atp+synthase+(complex+v)/monoclonal+antibody+raised+against+the+complete+mitochondrial+atp+synthase++complex+v+/pm22227919-54-11-3
Average 90 stars, based on 1 article reviews
monoclonal antibody raised against the complete mitochondrial atp synthase (complex v) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of oligomycin, CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).

Journal: Theranostics

Article Title: Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism

doi: 10.7150/thno.88223

Figure Lengend Snippet: Roxadustat promotes a metabolic shift to increased glycolytic energy production. The bioenergetic state of (A-C) neurons and (E-G) astrocytes treated with 10 µM roxadustat for 24 h were determined using a Seahorse XF96e Analyzer. DMSO treated cells were used as control (Ctrl). (A, E) Cell glycolytic profile was evaluated by using the Glycolytic Rate Assay. Proton efflux rate (PER) and oxygen consumption rate (OCR) were measured under basal conditions and in response to rotenone/antimycin A and 2-deoxy-D-glucose (2-DG). Glycolytic PER (GlycoPER) was calculated to determine basal glycolysis and compensatory glycolysis (in response to Rot/AA) ( n = 6-12 per group; unpaired two-tailed Student's t test; * p < 0.05, ** p < 0.01, *** p < 0.001). (B, F) Cell Mito Stress Test was applied to estimate key parameters of mitochondrial respiration. OCR was measured after sequential addition of oligomycin, CCCP, and Rot/AA to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ) ( n = 8-11 per group; unpaired two-tailed Student's t test; ** p < 0.01). (C, G) Energy Map depicting the relative bioenergetic state of Ctrl and roxadustat treated cells. (D, H) Cellular AMP, ADP and ATP levels were measured by LC-MS/MS technique and the ATP/ADP and ATP/AMP ratios were calculated ( n = 4-7 per group; unpaired two-tailed Student's t test).

Article Snippet: OCR and ECAR were measured under basal conditions and in response to sequential injections of 1 μg/mL oligomycin (ATP Synthase / Complex V inhibitor; Merck Millipore, #495455), 2 μM CCCP (carbonylcyanide-3-chlorophenylhydrazone, mitochondrial uncoupler; Merck Millipore, #C2759), and 1 μM rotenone (Merck Millipore, #R8875) plus 1 mg/mL antimycin A (Merck Millipore, #A8674) to calculate basal respiration (= OCR basal - OCR Rot/AA ), ATP production-linked respiration (= (OCR basal - OCR Oligo ) - OCR Rot/AA ) and maximal respiration (= OCR CCCP - OCR Rot/AA ).

Techniques: Control, Two Tailed Test, Liquid Chromatography with Mass Spectroscopy